SCKT

SCKT is a $5M micro-cap in structural decline. Revenue has fallen every year but one since FY2021 ($23.2M → $15.1M), down 19.6% in FY2025 alone, and the business is now unprofitable at the operating line (-$3.22M, -21.3% margin). The FY2025 net loss of $14.4M (EPS -$1.81) dwarfs the operating loss, so ~$11M is a below-operating, largely non-cash charge — operating cash flow was only -$1.25M — but the result still gutted the balance sheet: stockholders' equity collapsed 76% to $4.28M, retained earnings sit at -$64.6M, and liabilities are now 2.37x equity. The one genuine strength is a still-healthy 49.7% gross margin, but that hasn't been enough to cover opex as the top line erodes.

The filing language confirms the balance-sheet stress is the story. Management explicitly warns 'we may not return to profitability' and, if they can't, 'we may need to suspend some or all of our current operations.' They funded FY2025 with $1.5M of convertible notes and lean on a $1.0M revolver that matures July 31, 2026 — with only $2.03M of cash against rising current liabilities ($8.44M, +22.5%), the company is running close to the edge. The convertible financing and share count already up 9% YoY point to further dilution as the most likely path to survival, and the 10-K flatly cautions that additional capital 'may not be available on reasonable terms, if at all' and could cause 'substantial dilution.'